Skip to main content

UBS Group AG

Position in MREO — Mereo BioPharma Group plc

CIK 1610520 ZURICH, V8

Position in MREO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$460,344
-$31,395 QoQ
Shares Held
1,447,627
-2.9% QoQ
Ownership
0.907%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 58 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MREO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. MREO ranks #300 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MREO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $460,344 1,447,627
2026-03-31 $491,739 1,490,128
2025-12-31 $650,073 1,558,931
2025-09-30 $1,999,573 970,667
2025-06-30 $1,012,197 373,505
2025-03-31 $2,097,047 932,021
2024-12-31 $9,268,489 2,648,140
2023-12-31 $6,498 2,813
2023-06-30 $3,288 2,491
2023-03-31 $67,982 96,157
2022-12-31 $96,405 128,541
2022-09-30 $144,221 167,505
2022-06-30 $44,800 40,000
2021-12-31 $37,289 23,306
2021-09-30 $24,076 9,949
2021-06-30 $2,948 930
2021-03-31 $17,250 5,119
2020-12-31 $16,607 4,639
2020-09-30 $479 183
2020-06-30 $2,952 965
2020-03-31 $1,901 1,820